Congressional disclosures
| Office | Representative (TX-7) |
|---|---|
| Disclosed events | 6 |
| Purchases, all years | 3 |
| Sales | 3 |
| Publicly available | Transaction date | Asset | Action | Owner | Reported amount |
|---|---|---|---|---|---|
| 2018-09-05 | 2018-08-13 | AAPL | sale | not_indicated | $15,001 - $50,000 |
| 2018-09-05 | 2018-08-29 | AAPL | sale | not_indicated | $15,001 - $50,000 |
| 2017-06-27 | 2017-06-12 | Inmate Immunotherapeutic | sale | not_indicated | A $1,001- $15,000 |
| 2017-04-06 | 2017-01-25 | AAPL | purchase | not_indicated | A $1,001- $15,000 |
| 2017-04-06 | 2017-01-26 | Innate Immunotherapeutic | purchase | not_indicated | A $1,001- $15,000 |
| 2017-04-06 | 2017-04-03 | AAPL | purchase | not_indicated | A $1,001- $15,000 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.